Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
05/24/2007 | CA2630680A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer~s disease, neurodegeneration and dementia. |
05/24/2007 | CA2629781A1 Aminopyrimidines useful as kinase inhibitors |
05/24/2007 | CA2629468A1 Pyrazolyl urea derivatives useful in the treatment of cancer |
05/24/2007 | CA2629317A1 Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
05/24/2007 | CA2628650A1 Quinazolines useful as modulators of voltage gated ion channels |
05/23/2007 | EP1787982A2 11Beta-Hydroxysteroid dehydrogenase type 1 active compounds |
05/23/2007 | EP1786806A1 Dpp-iv inhibitors |
05/23/2007 | EP1786803A1 Pyrimidinylpyrazoles as tgf-beta inhibitors |
05/23/2007 | EP1786802A1 Pyrimidinylimidazoles as tgf-beta inhibitors |
05/23/2007 | EP1786801A1 Cytokine inhibitors |
05/23/2007 | EP1786800A2 Substituted biaryl piperazinyl-pyridine analogues |
05/23/2007 | EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists |
05/23/2007 | EP1786779A1 4-arylazo-3,5-diamino-pyrazole compounds and use thereof |
05/23/2007 | EP1786777A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
05/23/2007 | EP1786773A1 Isoindolin-1-one derivatives |
05/23/2007 | EP1786770A1 N-(1-(2,3-dihydro-1h-inden-5yl) -2-oxo-3-pyrrolidinyl) -sulfonamide derivatives for use as factor xa inhibitors |
05/23/2007 | EP1786769A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
05/23/2007 | EP1786427A2 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
05/23/2007 | EP1585743B1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
05/23/2007 | EP1238974B1 Heterocycle derivatives and drugs |
05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
05/23/2007 | CN1968949A Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
05/23/2007 | CN1968948A Processes for preparing gonadotropin releasing hormone receptor antagonists |
05/23/2007 | CN1968947A Heterocyclic condensed compounds useful as antidiuretic agents |
05/23/2007 | CN1968945A Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
05/23/2007 | CN1968937A Pyrimidin-4-one derivatives and their use as P38 kinase modulators |
05/23/2007 | CN1968923A Method for producing acetamidopyrrolidine derivative and intermediate compound thereof |
05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
05/22/2007 | US7220777 Lactam derivatives as antagonists for human 11cby receptors |
05/22/2007 | US7220774 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators |
05/22/2007 | US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents |
05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
05/22/2007 | US7220770 preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1; arthritis treament |
05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
05/22/2007 | US7220763 Indole-type derivatives as inhibitors of p38 kinase |
05/22/2007 | US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders |
05/22/2007 | US7220746 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
05/22/2007 | US7220745 Viricides; therapy for hepatitis virus infections |
05/22/2007 | US7220739 Therapeutic application of pro-apoptotic benzodiazepines |
05/22/2007 | US7220736 Pyrimidine compounds |
05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
05/22/2007 | CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds |
05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
05/18/2007 | WO2007056330A1 Benzimidazole derivatives as gyrase inhibitors |
05/18/2007 | WO2007056228A2 5-lipoxygenase-activating protein (flap) inhibitors |
05/18/2007 | WO2007056220A2 5-lipoxygenase-activating protein (flap) inhibitors |
05/18/2007 | WO2007056155A1 Heterocyclic compounds as tyrosine kinase modulators |
05/18/2007 | WO2007056075A2 Six membered heteroaromatic inhibitors targeting resistant kinase mutations |
05/18/2007 | WO2007056023A2 Thiazole inhibitors targeting resistant kinase mutations |
05/18/2007 | WO2007056021A2 5-lipoxygenase-activating protein (flap) inhibitors |
05/18/2007 | WO2007054979A1 Process for the large scale production of rizatriptan benzoate |
05/18/2007 | WO2007054748A1 Indole derivatives as antitumoural compounds |
05/18/2007 | WO2007054739A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
05/18/2007 | WO2007054480A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
05/18/2007 | WO2007054453A2 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa |
05/18/2007 | WO2007035841A9 Analogs of dehydrophenylahistins and their therapeutic use |
05/18/2007 | WO2007029086A3 Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors |
05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
05/18/2007 | WO2007028083A3 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
05/18/2007 | WO2007023073A3 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
05/18/2007 | WO2006081807A3 Method for the production of losartan |
05/18/2007 | CA2669736A1 Heterocyclic compounds as tyrosine kinase modulators |
05/18/2007 | CA2628934A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
05/18/2007 | CA2628624A1 Indole derivatives as antitumoural compounds |
05/18/2007 | CA2627808A1 Aminopyrimidines useful as kinase inhibitors |
05/18/2007 | CA2627426A1 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa |
05/18/2007 | CA2627263A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
05/18/2007 | CA2626685A1 Benzimidazole derivatives as gyrase inhibitors |
05/17/2007 | US20070112195 metalating a nicotines with lithium teramethylpipridine in presence of trialkyl or aryltin halide to form an intermediate such as 1-methylpyrrolidin-2-yl)-2-tricyclohexylstannanyl)pyridine, halogenating intermediate with I2, Br2 or N-bromosuccinimide; nicotinic acetylcholine receptor modulator |
05/17/2007 | US20070112055 Crystalline forms of almotriptan and processes for their preparation |
05/17/2007 | US20070112037 Pyrazole Derivatives |
05/17/2007 | US20070112036 Opioid receptor antagonists |
05/17/2007 | US20070112034 2-(benzimidazol-1-yl)-acetamide bisaryl derivatives |
05/17/2007 | US20070112033 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions |
05/17/2007 | US20070112012 Carbocyclic fused cyclic amines |
05/17/2007 | US20070112009 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them |
05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
05/17/2007 | US20070111998 Novel heterocyclic compounds as pSTAT3/IL-6 inhibitors |
05/17/2007 | US20070111992 Cathepsin K and cathepsin S dependent disorders such as osteoporosis, atherosclerosis, inflammation and immune disorders such as rheumatoid arthritis and chronic pain; e.g. 4-(piperazin-1-yl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile |
05/17/2007 | US20070111982 Calcitonin Gene-Related Peptide, CGRP; treatment of migraine and cluster headache; 2,5-dioxo-3',4'-dihydro-spiro(imidazolidine-4,2'(1'H)-naphthalene)-6'-carboxamides |
05/16/2007 | EP1785418A1 Pyrazole derivative |
05/16/2007 | EP1784401A1 Urea derivatives as calcium channel blockers |
05/16/2007 | EP1784400A1 Histamine h3 receptor agents, preparation and therapeutic uses |
05/16/2007 | EP1784399A2 Pyrimidine derivatives |
05/16/2007 | EP1784398A1 Purification of olmesartan medoxomil |
05/16/2007 | EP1784397A1 5-(1,1'-biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use |
05/16/2007 | EP1784393A1 Quinazolines useful as modulators of ion channels |
05/16/2007 | EP1784392A2 Pyrimidine derivatives |
05/16/2007 | EP1784187A2 Androgen receptor modulators |
05/16/2007 | EP1303307B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
05/16/2007 | CN1964970A Iap的抑制剂 Iap inhibitors |
05/16/2007 | CN1964946A 2-propylene-1-ones as hsp70 inducer |
05/16/2007 | CN1964944A Indole derivatives as antiviral agents |
05/16/2007 | CN1962656A Indomethacin 5-fluorouracil methyl ester pharmaceutical compound and its formulation and preparation method |
05/16/2007 | CN1962641A Metalloproteinase inhibitors |
05/16/2007 | CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
05/16/2007 | CN1315823C New method for synthesizing Ramosetron Hydrochloride |
05/16/2007 | CN1315811C Pyrimidine derivatives and preparing method thereof |